Description
Additional file 8. Figure S5: The myCAF signature is not associated with survival in a particular PAM50 breast cancer subtype. Kaplan-Meier curve showing breast cancer survival of PAM50 subtypes stratified according to low (67%, red) expression of the myCAF signature (≥100 FPKM, ≥2-fold change between myCAF versus iCAF, adjusted p< 0.0001) with 10- and 15 years follow-up in data from TCGA. Association was tested by the log-rank test and none reached the statistical significance level of 0.05. Number of patients at risk at the indicated time points are shown below each plot.
Date made available | 2024 |
---|---|
Publisher | figshare |